Fox Run Management’s Supernus Pharmaceuticals SUPN Stock Holding History

Fox Run Management’s Portfolio SUPN Stock Details SUPN Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$640K	Buy
2025 Q1	–	Sell
2024 Q4	$1.3M	Buy
2019 Q2	–	Sell
2019 Q1	$562K	Buy
2018 Q2	–	Sell
2018 Q1	$736K	Sell
2017 Q4	$876K	Buy
2016 Q1	–	Sell
2015 Q4	$207K	Buy